• OPEN AN ACCOUNT
Indian Indices
Sensex
76,909.68 -325.78
( -0.42%)
Global Indices
Nasdaq
53,487.79 123.39
(0.23%)
Dow Jones
7,729.14 16.38
(0.21%)
Hang Seng
65,335.94 -2,124.79
(-3.15%)
Nikkei 225
10,747.45 19.41
(0.18%)
Forex
USD-INR
95.60 0.07
(0.07%)
EUR-INR
110.76 0.24
(0.21%)
GBP-INR
129.56 0.29
(0.22%)
JPY-INR
0.60 0.00
(0.12%)

EQUITY - MARKET SCREENER

Emcure Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
544210
INE168P01015
195.6288102
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
EMCURE
43.42
35938.7
EPS(TTM)
Face Value()
Div & Yield %
43.64
10
0.19
 

Shraddha Prime Projects consolidated net profit rises 245.89% in the March 2026 quarter
May 29,2026
Net profit of Shraddha Prime Projects rose 245.89% to Rs 23.14 crore in the quarter ended March 2026 as against Rs 6.69 crore during the previous quarter ended March 2025. Sales rose 287.02% to Rs 186.31 crore in the quarter ended March 2026 as against Rs 48.14 crore during the previous quarter ended March 2025.

For the full year,net profit rose 118.59% to Rs 53.86 crore in the year ended March 2026 as against Rs 24.64 crore during the previous year ended March 2025. Sales rose 226.75% to Rs 508.35 crore in the year ended March 2026 as against Rs 155.58 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales186.3148.14 287 508.35155.58 227
OPM %12.6317.03 -13.0419.64 -
PBDT30.109.35 222 78.7434.81 126
PBT30.069.33 222 78.6034.75 126
NP23.146.69 246 53.8624.64 119